Literature DB >> 34084107

Work and School Absenteeism in Inflammatory Bowel Disease Patients in Jeddah, Saudi Arabia: A Cross-Sectional Study.

Mahmoud H Mosli1,2, Abdullah A Alamri1, Omar I Saadah2,3.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD), which can have a considerable effect on quality of life, productivity and performance, is typically diagnosed during periods of life in which patients have academic and career-related responsibilities.
OBJECTIVE: The objective of the study was to determine the effect of IBD symptoms on work and school absenteeism in patients from Saudi Arabia. PATIENTS AND METHODS: This cross-sectional survey included patients diagnosed with IBD, aged >8-60 years, at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. The validated 32-question IBD quality-of-life questionnaire was used to elicit information regarding quality of life and another 9-question validated questionnaire was used to assess work and school absenteeism. A logistic regression analysis was used to identify possible determinants of absenteeism.
RESULTS: A total of 123 IBD patients were included, with a 1:1 male-to-female ratio. The median age at presentation was 26 years (range: 8-59 years), 56.9% had Crohn's disease, and 43.1% had ulcerative colitis. Further, 58 (47.2%) were employed, 49 (39.8%) were students and 16 (13%) were unemployed. Forty-seven (43.9%) participants reported absenteeism: 26 were employees (55.3%) and 21 were students (44.7%). A binary logistic regression analysis identified IBD subtype (P = 0.006) and the presence of perianal disease (P = 0.028) as clinical predictors for absenteeism from school or work. A feeling of abdominal pain (P = 0.015), fatigue (P = 0.015) and difficulty taking part in social engagements (P < 0.001) were also significantly associated with absenteeism.
CONCLUSIONS: A sizeable proportion of the participants reported absenteeism owing to the effects of IBD. IBD subtype, perianal disease, presence of ongoing abdominal pain, fatigue and difficulty in social engagement were strongly associated with nonattendance. Copyright:
© 2021 Saudi Journal of Medicine & Medical Sciences.

Entities:  

Keywords:  Absenteeism; inflammatory bowel disease; nonattendance; school attendance; work productivity

Year:  2021        PMID: 34084107      PMCID: PMC8152386          DOI: 10.4103/sjmms.sjmms_79_20

Source DB:  PubMed          Journal:  Saudi J Med Med Sci        ISSN: 2321-4856


INTRODUCTION

Inflammatory bowel disease (IBD) is a group of immune-mediated inflammatory conditions of the gastrointestinal tract, comprising mainly of Crohn's disease (CD) and ulcerative colitis (UC), which tend to have a chronic relapsing–remitting behavior, primarily involving the bowel.[1] Lack of control of the disease may have a considerable negative effect on patient's quality of life, employment status, productivity at work and performance in school.[23] Several studies have found that IBD patients have higher rates of unemployment compared to the general population.[45] Unemployment rates of up to 45% have been reported in CD patients in different studies.[6789] A Swedish study recently found that patients with CD had higher work loss and number of lost workdays in the 5 years before diagnoses than the comparators, and this was more pronounced in the year before the diagnosis.[10] Such work loss also translates into indirect financial loss through diminished earnings, poor productivity and increased unpaid sick leave days. Similarly, higher proportions of documented sick days have also been reported in patients with UC compared with matched controls.[11] Younger IBD patients may have frequent absenteeism from school and university because of digestive symptoms and fatigue, as well as requiring the rescheduling of events, which, in turn, can have a negative impact on their education and psychological well-being.[1213] Despite the absence of a national registry that accurately captures all cases of IBD, recent data suggest a sharp increase in the incidence of IBD in the Kingdom of Saudi Arabia.[141516] However, to the best of the authors' knowledge, no study has previously focused on work and school absenteeism in IBD patients from Saudi Arabia. The aim of this study was to estimate the prevalence of absenteeism from work or school in a cohort of patients with IBD.

MATERIALS AND METHODS

This cross-sectional survey included all patients with IBD aged >8–60 years who regularly followed up at the Gastroenterology Clinic at King Abdulaziz University (KAU) Hospital, Jeddah, Saudi Arabia, between January 2016 and December 2018. KAU Hospital is considered one of the primary governmental tertiary hospitals in the region and the IBD unit is regarded as an important referral centers in the area. The study included both genders and all nationalities. For patients aged <18 years, the parents/guardians completed the questionnaire. Patients with severe comorbidities, major psychiatric illnesses and aged <8 years or >60 years and those who did not consent to participation were not included in the study. Demographics, clinical, endoscopic and laboratory data were collected using a standard data extraction sheet, and the entered data were cross-verified by another author. Data collection and the survey were suspended during holiday and student examination periods. This study was approved by the Biomedical Ethics Unit at KAU, and written informed consent was obtained from the patients or guardians for patients aged <18 years.

Questionnaires

Two questionnaires were used to separately assess health-related quality of life (HRQOL) and work and school absenteeism. For the former, the shortened version of the IBD quality-of-life (IBDQ-32) questionnaire was used. The IBDQ-32 is a validated tool that considers different aspect of patients' quality of life. It uses 32 closed ended questions.[17] Work and school absenteeism was assessed using a previously published and validated questionnaire, which included nine questions.[13] Both the questionnaires were in English and were scored using a 5- or 7-point Likert-type scale (higher scores were considered better). While the participants or guardians completed the questionnaires, one of the researchers was available to clear any ambiguities or translate into Arabic when required.

Outcomes and definitions

The primary outcome of the study was to determine the rate of work or school absenteeism and its relation to other variables. The secondary outcome was to identify predictors of absenteeism and measure the prevalence of unemployment. For the purposes of categorization, “employed” was defined as engaged in a full-time occupation during the 4 weeks prior to the survey, whether contracted by others or self-employed; “student” was defined as currently enrolled at an educational institution at any educational level, whether in person or through distance learning, and “absenteeism” was defined as any illness-related leave from work or school (i.e., inability to fulfill occupational or educational duties owing to IBD, directly or indirectly) 2 weeks prior to the survey. Both full-day absences and half-day absences that impacted work or school performance were considered. The 2-week recall period was chosen based on its use in several QOL-related studies on IBD patients.[18]

Statistical analysis

Estimates of means ± standard deviations and medians were used for normally distributed and skewed continuous variables, respectively. Frequencies were reported for categorical variables. An independent samples t-test and a Mann–Whitney U-test were used to compare means and medians, respectively, while the Chi-squared test was used to compare frequencies. Nonresponse error was considered as missing results or questionnaires, and >20% missing data were defined as a partial response. A binary logistic regression analysis was used to identify binary predictors of outcomes; unemployed participants were excluded from this part of the analysis. STATA 11.2 (StataCorp, Texas, USA) software was used for the analysis, with the statistical significance set at P = 0.05.

RESULTS

Baseline characteristics

A total of 123 patients were included in the study. The median age of the participants was 26 years (range: 8–59 years). Seventy-nine percent of the cohort were Saudi. The majority of the patients (59%) were 18–40 years of age, and the male–female representation was approximately 1:1. In terms of the condition, 56.9% (n = 70) had CD and 43.1% (n = 53) had UC. The most common disease location in CD patients was the colon (57.1%), and the most common disease behavior was nonstricturing and nonpenetrating (67.1%). For patients with UC, left-sided colitis was the most common disease distribution (56.6%). Severe disease contributed to 58.5% of the cases (n = 72). One or more of the extraintestinal manifestations were reported in 22.8% of the participants. Of the total participants, 58 (47.2%) were employed, 49 (39.8%) were students and 16 (13%) were unemployed [Table 1].
Table 1

Baseline demographic and clinical characteristics of the study cohort (n=123)

Baseline characteristicsSummary statistics, mean±SD or n (%)
Demographics
 Mean age (years)29.7±12.8
 Age categories (years)
  0-1824 (19.5)
  18-4073 (59.3)
  40-6026 (21.1)
 Female gender61 (49.6)
 Saudi nationality97 (78.9)
 Smoking25 (20.3)
 Family history of IBD16 (10.6)
Diagnosis
 Crohn’s disease70 (56.9)
 Ulcerative colitis53 (43.1)
Disease location (CD)
 L1: Terminal ileal5 (7.1)
 L2: Colonic40 (57.1)
 L3: Ileo-colonic25 (35.7)
Disease behavior (CD)
 B1: Nonstricturing, nonpenetrating47 (67.1)
 B2: Stricturing7 (10)
 B3: Penetrating16 (22.9)
 Perianal disease15 (11.2)
Disease extension (UC)
 E1. Ulcerative proctitis1 (1.9)
 E2. Left sided UC30 (56.6)
 E3. Pancolitis22 (41.5)
IBD severity
 Mild to moderate51 (41.5)
 Severe72 (58.5)
 EIMs28 (22.8)
 Aphthous stomatitis20 (16.3)
 Arthritis25 (20.3)
 Primary sclerosing cholangitis2 (1.6)
 Erythema nodosum3 (2.4)
Medications
 Mesalamine42 (34.1)
 Azathioprine44 (35.8)
 Methotrexate3 (2.4)
 Adalimumab32 (26)
 Infliximab21 (17.1)
Surgery
 Colectomy8 (6.5)
 Small bowel resection6 (4.9)
 Pouch surgery2 (1.6)

SD – Standard deviation; CD – Crohn’s disease; IBD – Inflammatory bowel disease; UC – Ulcerative colitis; EIMs – Extraintestinal manifestations

Baseline demographic and clinical characteristics of the study cohort (n=123) SD – Standard deviation; CD – Crohn’s disease; IBD – Inflammatory bowel disease; UC – Ulcerative colitis; EIMs – Extraintestinal manifestations

Outcomes

A total of 47 (43.9%) participants, excluding the unemployed, reported absenteeism from work/school in the 2 weeks prior to the survey. Of these, 26 were employees (55.3%) and 21 were students (44.7%). A bivariate analysis of attendance status for work and schools in relation to various demographic and clinical variables revealed a statistically significant difference according to the IBD subtype, in which CD patients had a higher rate of absenteeism than UC patients (35/63 [55.5%] vs. 12/44 [27.3%]; P = 0.004) [Table 2]. There was no statistically significant difference in the frequency of absenteeism when categorized based on age: 0–18 years, 9/24 (37.5%); 18–40 years, 31/63 (49.2%) and 40–60 years, 7/20 (35%) (P = 0.41). There was a significant association between absenteeism and the presence of perianal disease (absent: 9/47 [19.1%]; attended: 3/57 [5.3%]; P = 0.02) and the presence of extraintestinal manifestations (absent: 15/47 [31.9%]; attended: 8/60 [13.3%]; P = 0.02). No statistically significant difference was detected when stratifying participants according to disease severity: 22/44 (50%) had mild-to-moderate severity and 25/63 (39.7%) had severe disease (P = 0.29). When stratifying by IBD subtypes, no statistically significant difference was observed in the frequency of absenteeism between mild-to-moderate and severe CD (15/25 [60%] vs. 20/38 [52.6%], respectively; P = 0.57), and between mild-to-moderate and severe UC (7/19 [36.8%] vs. 5/25 [20%], respectively; P = 0.21).
Table 2

Bivariate analysis of variables according to school and work attendance status (n=107)

VariableAbsents (n=47), n (%)Attended (n=60), n (%)P*
Demography
 Gender
  Male26 (55)34 (56.7)0.89
  Female21 (45)26 (55.3)
 Nationality
  Saudi37 (78.7)47 (78.3)0.96
  Non-Saudi10 (21.3)13 (21.7)
 Age category (years)
  0-189 (19)15 (25)0.41
  18-4031 (66)32 (53.3)
  40-607 (15)13 (21.7)
 Smoking
  Yes10 (21.3)12 (20)0.87
  No37 (78.7)48 (80)
 Family history of IBD
  Yes2 (4.3)8 (13.3)0.11
  No45 (95.7)52 (86.7)
Clinical features
 Diagnosis
  Crohn’s disease35 (74.5)28 (46.7)0.004**
  Ulcerative colitis12 (25.5)32 (53.3)
 CD location
  L1: Terminal Ileal1 (2.8)2 (7.1)0.08
  L2: Colonic17 (48.6)20 (71.4)
  L3: Ileo-colonic17 (48.6)6 (21.4)
 Perianal disease
  Yes9 (19.1)3 (5.0)0.02**
  No38 (80.9)57 (95)
 CD disease behavior
  B1. Nonstricturing nonpenetrating24 (68.6)18 (64.3)0.66
  B2. Stricturing4 (11.4)2 (7.1)
  B3. Penetrating7 (20)8 (28.6)
 Disease Extension (UC)
  E1. Ulcerative proctitis0 (0.0)1 (3.1)0.23
  E2. Left-sided UC9 (75)15 (46.9)
  E3. Pancolitis3 (25)16 (50)
 IBD disease severity
  Mild to moderate25 (53.2)38 (63.3)0.29
  Severe22 (46.8)22 (36.7)
 Extraintestinal manifestations
  Yes15 (31.9)8 (13.3)0.02**
  No32 (68.1)52 (86.7)
Medical treatment
 Mesalamine
  Yes17 (36.2)19 (31.7)0.63
  No30 (63.8)41 (68.3)
 Azathioprine
  Yes17 (36.2)23 (38.3)0.82
  No30 (63.8)37 (61.7)
 Adalimumab
  Yes12 (25.5)15 (25)0.95
  No35 (74.5)45 (75)
 Infliximab
  Yes11 (23.4)7 (11.7)0.11
  No36 (76.6)53 (88.3)
Surgery
 Colectomy
  Yes4 (8.5)3 (5.0)0.47
  No43 (91.5)57 (95)
 Small bowel resection
  Yes1 (2.1)2 (3.3)0.71
  No46 (97.9)58 (96.7)

*Chi-square/Fisher’s exact tests; **P<0.05. CD – Crohn’s disease; IBD – Inflammatory bowel disease; UC – Ulcerative colitis

Bivariate analysis of variables according to school and work attendance status (n=107) *Chi-square/Fisher’s exact tests; **P<0.05. CD – Crohn’s disease; IBD – Inflammatory bowel disease; UC – Ulcerative colitis A binary logistic regression analysis confirmed that IBD subtypes (odds ratio [OR] = 3.7, 95% CI = 1.45–9.46, P = 0.006) and the presence of perianal disease (OR = 7.3, 95% CI = 1.24–42.33, P = 0.028) were predictors for absenteeism from work and school, following adjustment for other confounding variables [Table 3].
Table 3

Predictors of work and school absenteeism in the study cohort (n=107)

VariablesBSEOR95% CIP

LowerUpper
Gender−0.0100.460.990.412.440.98
Age category (years)
0-18
19-40
41-60−0.1930.360.830.411.660.59
Family history of IBD1.4670.884.340.7724.430.09
IBD subtypes1.3090.483.701.459.460.006*
Crohn’s disease
Ulcerative colitis
Perianal disease1.9820.907.261.2442.330.028*
Extraintestinal manifestations1.1710.603.230.9910.480.05
Thiopurines0.4090.571.510.494.570.47
Adalimumab−0.1540.590.860.272.720.79
Infliximab−0.6710.690.510.131.970.33
Colectomy0.2541.071.290.1610.510.81
Small bowel resection−0.1842.180.840.0159.340.93

*P<0.05. IBD – Inflammatory bowel disease; SE – Standard error; OR – Odds ratio; CI – Confidence interval

Predictors of work and school absenteeism in the study cohort (n=107) *P<0.05. IBD – Inflammatory bowel disease; SE – Standard error; OR – Odds ratio; CI – Confidence interval

Relation between patient-reported quality-of-life measures and school and work attendance status

The main QOL items of various domains were examined through a bivariate analysis to test for various associations with absenteeism from school or work [Table 4]. In the bowel domain, the following items were statistically significant: frequent loose bowel motions (59.6% in those who were absent vs. 38.3% in those who attended; P = 0.03), frequent abdominal pain (87.2%) versus 27 (45%), P < 0.001), frequent bloating (70.2% vs. 36.7%; P = 0.001), passing large amounts of gas (72.3% vs. 48.3%, P = 0.012) and a consistent feeling of wanting to go to the bathroom (59.6% vs. 33.3%; P = 0.007). In the systemic domain, feeling fatigue (76.6% vs. 35%; P < 0.001), having difficulty maintaining weight (55.3% vs. 33.3%; P = 0.023) and having trouble with sleep (66% vs. 28.3%; P < 0.001) were statistically significant. In the emotion domain, being worried about needing surgery (48.9% vs. 21.7%; P = 0.003), fear of not finding a bathroom (68.1% vs. 33.3%; P < 0.001), feeling worried and anxious (70.2% vs. 43.3%; P = 0.006) and feeling angry (53.2% vs. 30%; P = 0.015) were statistically significant. In the social domain, delaying or cancelling social engagements (68.1% vs. 8.3%; P < 0.001) and being embarrassed for soiling or having an unpleasant stool odor (29.8% vs. 13.3%; P = 0.04) were statistically significant.
Table 4

Patients reported quality-of-life measures associated with work and school absenteeism (bivariate analysis)

Main domains and itemsAbsents, n (%)Attended, n (%)P*
Bowel
 Frequent loose bowel motions
  Yes28 (59.6)23 (38.3)0.03**
  No19 (40.4)37 (61.7)
 Frequent abdominal pain
  Yes41 (87.2)27 (45)<0.001**
  No6 (12.8)33 (55)
 Frequent bloating
  Yes33 (70.2)22 (36.7)0.001**
  No14 (29.8)38 (63.3)
 Passing large amount of gases
  Yes34 (72.3)29 (48.3)0.012**
  No13 (27.7)31 (51.7)
 Rectal bleeding
  Yes7 (14.9)12 (20)0.49**
  No40 (85.1)48 (80)
 Feeling of having to go to bathroom
  Yes28 (59.6)20 (33.3)0.007**
  No19 (40.4)40 (66.7)
Systemic
  Feeling fatigue
  Yes36 (76.6)21 (35)<0.001**
  No11 (23.4)39 (65)
 Problem in maintaining weight
  Yes26 (55.3)20 (33.3)0.023**
  No21 (44.7)40 (66.7)
 Troubled sleep
  Yes31 (66)17 (28.3)<0.001**
  No16 (34)43 (71.7)
Emotion
 Worried about needing surgery
  Yes23 (48.9)13 (21.7)0.003**
  No24 (51.1)47 (78.3)
 Fear of not finding a bathroom
  Yes32 (68.1)20 (33.3)<0.001**
  No15 (31.9)40 (66.7)
 Feeling depressed
  Yes22 (46.8)23 (38.3)0.38
  No25 (53.2)37 (61.7)
 Feeling worried or anxious
  Yes33 (70.2)26 (43.3)0.006**
  No14 (29.8)34 (56.7)
 Feeling relaxed
  Yes30 (63.8)34 (56.7)0.45
  No17 (36.2)26 (43.3)
 Feeling angry
  Yes25 (53.2)18 (30)0.015**
  No22 (46.8)42 (70)
 Personal life satisfaction
  Yes41 (87.2)49 (81.7)0.43
  No6 (12.8)11 (18.3)
Social
 Delaying or cancelling social engagement
  Yes32 (68.1)5 (8.3)<0.001**
  No15 (31.9)55 (91.7)
 Difficulty on sport activities
  Yes17 (36.2)15 (25)0.21
  No30 (63.8)45 (75)
 Embarrassed as a result of soiling or unpleasant odor
  Yes14 (29.8)8 (13.3)0.04**
  No33 (70.2)52 (86.7)
 Lack of understanding from others
  Yes9 (19.1)8 (13.3)0.41
  No38 (80.9)52 (86.7)

*Chi square/Fisher’s exact tests; **P<0.05

Patients reported quality-of-life measures associated with work and school absenteeism (bivariate analysis) *Chi square/Fisher’s exact tests; **P<0.05 After adjusting for confounding variables using a binary logistic regression analysis, the following items remained statistically significant: frequent feeling of abdominal pain (OR = 8.3, 95% confidence interval [CI] = 1.52–44.98; P = 0.015), feeling fatigue (OR = 5.5, 95% CI = 1.39–22.53; P = 0.015) and delaying or canceling social engagements (OR = 45, 95% CI = 6.19–334; P < 0.001) [Table 5].
Table 5

Binary logistic regression analysis of various patient-reported quality of life data in relation to work and school absenteeism (n=107)

VariablesBSEOR95% CIP

LowerUpper
Frequent loose bowel motions−0.8950.740.410.091.760.23
Frequent abdominal pain2.1110.878.261.5244.980.015*
Frequent bloating−0.2010.890.820.144.690.82
Passing large amount of gases−0.1320.760.880.193.910.86
Feeling of having to go to bathroom0.1690.721.180.294.850.82
Feeling fatigue1.6980.705.461.3921.530.015*
Problem maintaining weight−1.7501.140.170.021.640.13
Troubled sleep0.0341.031.040.147.820.97
Worried about needing surgery−0.4350.890.650.113.690.63
Fear of not finding a bathroom0.8870.872.430.4413.470.31
Feeling worried or anxious−0.6310.880.530.0952.970.47
Feeling angry0.8430.722.320.579.480.24
Delaying or cancelling social engagement3.8181.0245.496.19334.03<0.001*
Embarrassed as a result of soiling or unpleasant odor−1.6081.010.200.031.450.11

*P<0.05. SE – Standard error; OR – Odds ratio; CI – Confidence interval

Binary logistic regression analysis of various patient-reported quality of life data in relation to work and school absenteeism (n=107) *P<0.05. SE – Standard error; OR – Odds ratio; CI – Confidence interval

DISCUSSION

IBD comprises a set of chronic illnesses that can dramatically influence patient quality of life, involving various mechanisms that extend from the presence of persistent symptomatology to the development of superimposed functional and mental disorders.[19] A growing body of literature has supported the notion that IBD treatment should target not only symptom relief and bowel mucosal healing but also quality of life.[2021] A good representation of patient quality of life status is the ability to maintain work and school attendance. Since absenteeism is frequently attributed to treatment failure, it may also be a marker of decline in quality of life.[2021] This study examined absenteeism in a cohort of Saudi patients with IBD and found that 55.3% of employees and 44.7% of students reported absenteeism from work and school in the past 2 weeks. This study found no statistically significant difference between absenteeism and age, which is in contrast with few studies where age has been associated with absenteeism. A recent study by Carreon et al.[17] examined school attendance in 161 adolescents and revealed that up to two-third of patients with IBD reported absence from school for various reasons, including follow-up visits to health centers, hospitalization and feeling unwell. The study found an association between older age and active disease as strong predictors of school absence. School-attending children and adolescents are at risk of suffering from compromised academic performance. Carreon et al.,[17] in their regression analysis, found that disease activity (P < 0.01) and older age (P = 0.03) accounted for 9% and 3%, respectively, of the variances in child-reported difficulties with being at school. In a case–control study regarding the effect of IBD on psychosocial and school performance parameters, Mackner et al.,[22] showed that adolescents with IBD reported significantly more full-day absences than healthy controls (P = 0.05). Patients are typically diagnosed with IBD at an age where they have many responsibilities, including employment requirements and social obligations. Inability to cope with this disease can have a negative impact on these activities.[22] A large cross-sectional study[23] carried out in Holland, involving 1092 IBD patients with a mean age of 47 years, reported relatively low quality of life data and found an association between employment difficulties and disease duration, IBD-related surgery and fecal incontinence and active perianal disease, after adjusting for age (OR = 0.67; 95% CI: 0.50–0.91; P = 0.01). Our study found a strong association with the presence of perianal disease (OR = 7.3, 95% CI = 1.24–42.33, P = 0.028), in agreement with Vollebregt et al.[23] A French web-based cross-sectional study surveyed 1410 patients with IBD about their work status and reported that 80% were actively employed, but half of those considered IBD a barrier to work;[24] fatigue and diarrhea were the most common restricting symptoms. A Japanese cross-sectional study revealed an unemployment rate of 12.3% among IBD patients (compared with an unemployment rate of 3.2% in the general population), which extended across all age groups but was more pronounced in those aged >50 years.[25] Unemployment was associated with older age, female gender, presence of depression, previous surgery and prescription of biologics. In Saudi Arabia, the unemployment rate in the general population was estimated to be approximately 5.9% in 2018,[26] but in the present cohort, unemployment rate was 13%. Absenteeism was associated with CD as an IBD subtype (P = 0.006) and the presence of perianal disease (P = 0.028). Absence from school and work was also associated with feeling abdominal pain (P = 0.015), fatigue (P = 0.015) and delaying or canceling social engagements (P < 0.001). This observation is consistent with some previous reports that have associated CD and perianal disease with work-related difficulties.[427] The current study highlights an important significant relationship between work and school performance and Saudi patients with IBD, and this is a novel contribution to the growing body of literature on IBD. Despite the limitation of being a cross-sectional study with a small sample size, the authors believe it may serve as a nidus for further large, prospectively conducted studies dedicated to probing the barriers and challenges that IBD patients face and their impact on quality of life. This study has identified CD diagnosis, ongoing abdominal pain and delaying or cancelling social engagement as strong predictors of absenteeism from work or school. These have important clinical implications in terms of interventions for management through appropriate control of symptoms in the clinic or through referral to other subspecialists, such as with respect to pain management, sleep hygiene and psychological and social support.

CONCLUSIONS

The results show that a large proportion of the studied cohort of IBD patients from Jeddah, Saudi Arabia, reported absenteeism from work/school. CD subtype, the presence of perianal disease, ongoing abdominal pain, fatigue and a lack of social engagement strongly predicted nonattendance.

Ethical considerations

The Ethical Research Committee, Biomedical Ethics Unit at KAU, approved the study prior to its commencement (Ref. no.: 418-1; date of approval: July 21, 2017). The study was conducted in adherence with the guidelines of Declaration of Helsinki, 2013, and all participants or guardians (for patients aged <18 years) provided their written informed consent.

Peer review

This article was peer-reviewed by two independent and anonymous reviewers.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  26 in total

1.  Academic achievement, attendance, and school-related quality of life in pediatric inflammatory bowel disease.

Authors:  Laura M Mackner; Robert M Bickmeier; Wallace V Crandall
Journal:  J Dev Behav Pediatr       Date:  2012-02       Impact factor: 2.225

2.  Incidence of pediatric inflammatory bowel disease in Saudi Arabia: a multicenter national study.

Authors:  Mohammad I El Mouzan; Omar Saadah; Khalid Al-Saleem; Mohammad Al Edreesi; Mohammed Hasosah; Aziz Alanazi; Mohammad Al Mofarreh; Ali Asery; Abdulaziz Al Qourain; Khaled Nouli; Abdulrahman Al Hussaini; Abdulwahab Telmesani; Khalid AlReheili; Sharifa Alghamdi; Nawal Alrobiaa; Abdullah Alzaben; Ahmad Mehmadi; Homoud Al Hebbi; Ahmad Al Sarkhy; Ali Al Mehaidib; Badr Al Saleem; Asaad Assiri; Sami Wali
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

3.  Impact of inflammatory bowel diseases on working life: A French nationwide survey.

Authors:  Catherine Le Berre; Laurent Peyrin-Biroulet; Anne Buisson; Alain Olympie; Marie-Hélène Ravel; Christina Bienenfeld; Florent Gonzalez
Journal:  Dig Liver Dis       Date:  2019-02-11       Impact factor: 4.088

Review 4.  The education and employment status of patients with inflammatory bowel diseases.

Authors:  Sheetal R Marri; Alan L Buchman
Journal:  Inflamm Bowel Dis       Date:  2005-02       Impact factor: 5.325

5.  Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease.

Authors:  Tomm Bernklev; Jørgen Jahnsen; Magne Henriksen; Idar Lygren; Erling Aadland; Jostein Sauar; Tom Schulz; Njål Stray; Morten Vatn; Bjørn Moum
Journal:  Inflamm Bowel Dis       Date:  2006-05       Impact factor: 5.325

6.  School Attendance in Children With Functional Abdominal Pain and Inflammatory Bowel Diseases.

Authors:  Amit Assa; Alona Ish-Tov; Firas Rinawi; Raanan Shamir
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-11       Impact factor: 2.839

Review 7.  Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index.

Authors:  B Lo; M V Prosberg; L L Gluud; W Chan; R W Leong; E van der List; M van der Have; H Sarter; C Gower-Rousseau; L Peyrin-Biroulet; I Vind; J Burisch
Journal:  Aliment Pharmacol Ther       Date:  2017-10-09       Impact factor: 8.171

8.  Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life.

Authors:  Paschalis Paschos; Anastasia Katsoula; Georgia Salanti; Olga Giouleme; Eleni Athanasiadou; Apostolos Tsapas
Journal:  Aliment Pharmacol Ther       Date:  2018-10-30       Impact factor: 8.171

9.  Disability in Patients with Inflammatory Bowel Disease: Correlations with Quality of Life and Patient's Characteristics.

Authors:  Konstantinos Argyriou; Andreas Kapsoritakis; Konstantinos Oikonomou; Anastassios Manolakis; Eirini Tsakiridou; Spyridon Potamianos
Journal:  Can J Gastroenterol Hepatol       Date:  2017-05-29

10.  Impacts of perianal disease and faecal incontinence on quality of life and employment in 1092 patients with inflammatory bowel disease.

Authors:  P F Vollebregt; A A van Bodegraven; T M L Markus-de Kwaadsteniet; D van der Horst; R J F Felt-Bersma
Journal:  Aliment Pharmacol Ther       Date:  2018-03-09       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.